GSFD yields 2760.91% · PFE yields 6.13%● Live data
📍 GSFD pulled ahead of the other in Year 1
Combined, GSFD + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GSFD + PFE for your $10,000?
Global Seafood Technologies, Inc. engages in the processing and packaging of shrimp for seafood restaurant chains and retail grocery outlets in the United States. The company operates through the Seafood, Fishing Bait, and Freshwater Shrimp segments. The Seafood segment performs processing, packaging, and storage of shrimp and other seafood products. The company provides frozen shrimp in various sizes and descriptions, which are packaged for commercial or consumer use. Frozen, headless shrimp with shell, is the principal product processed and packaged in one-pound and two-pound packages. Peeled shrimp is also processed under private labels for customers or for distribution to restaurants, and it is used in ready-to-cook meal kits for supermarket distribution. The Fishing Bait segment packages and distributes recreational fishing bait products. Its Killer Bee Bait products include varieties of bait shrimp, catfish bait, cut squid, whole squid, cigar minnows, ballyhoo, frozen chum, and menhaden oil. Killer Bee Bait products are sold through retail outlets and at independent marinas and bait shops. The Freshwater Shrimp segment engages in the development and harvesting of farm-grown and freshwater shrimp through its hatchery and nursery facility for sale to independent aquaculture farmers. Global Seafood Technologies is based in Biloxi, Mississippi.
Full GSFD Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.